Terns Pharmaceuticals Inc. (TERN) NASDAQ

$6.52 0.03 (0.46%)

Market Cap: $163.98M

As of 11/30/21 11:24 AM EST. Market open.

(TERN)

Terns Pharmaceuticals Inc. (TERN) NASDAQ

$6.52 0.03 (0.46%)

Market Cap: $163.98M

As of 11/30/21 11:24 AM EST. Market open.

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns’ programs are based on clinically validated and complementary mechanisms of action to address the multiple hepatic disease processes ... read more

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns’ programs are based on clinically validated and complementary mechanisms of action to address the multiple hepatic disease processes of NASH in order to drive meaningful clinical benefits for patients. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
Full Time Employees
30
Address
.
KEY STATS
Open
$6.52
Previous Close
$6.49
Days Range
$6.49 - $7.25
52 week range
$6.49 - $28.36
Volume
17,267
Avg. Volume (30 days)
48,544
Market Cap
$163.98M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
25,267,271
Open
$6.52
Previous Close
$6.49
Days Range
$6.49 - $7.25
52 week range
$6.49 - $28.36
Volume
17,267
Avg. Volume (30 days)
48,544
Market Cap
$163.98M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
25,267,271

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR TERNS PHARMACEUTICALS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
GORDON CARL L Director Feb 09, 2021 Buy $17.00 475,000 8,075,000 2,274,723 Feb 09, 2021, 03:10 PM
ORBIMED ADVISORS LLC Director Feb 09, 2021 Buy $17.00 475,000 8,075,000 2,274,723 Feb 09, 2021, 03:09 PM
Vivo Capital VIII, LLC 10% Owner Feb 09, 2021 Buy $17.00 103,372 1,757,324 2,036,557 Feb 09, 2021, 03:08 PM
Vivo Capital VIII, LLC 10% Owner Feb 09, 2021 Buy $17.00 357,353 6,075,001 357,353 Feb 09, 2021, 03:08 PM
Vivo Capital VIII, LLC 10% Owner Feb 09, 2021 Buy $17.00 14,275 242,675 281,223 Feb 09, 2021, 03:08 PM
Flynn James E 10% Owner Feb 09, 2021 Buy $17.00 665,000 11,305,000 2,382,033 Feb 09, 2021, 02:55 PM
Buy Sale Option Exercise
Owner Relationship Date Value($)
GORDON CARL L Director 02/09/2021 8,075,000
ORBIMED ADVISORS LLC Director 02/09/2021 8,075,000
Vivo Capital VIII, LLC 10% Owner 02/09/2021 1,757,324
Vivo Capital VIII, LLC 10% Owner 02/09/2021 6,075,001
Vivo Capital VIII, LLC 10% Owner 02/09/2021 242,675
Flynn James E 10% Owner 02/09/2021 11,305,000